In the article “Factors and Reasons Associated with Low COVID-19 Vaccine Uptake among Highly Hesitant Communities in the US.” by Saif Khairat, et al in the March issue of the American Journal of Infection Control (2022;50(3):262-67) the author degrees were incorrectly listed.
The correct names and degrees are as follows: Saif Khairat, PhD, MPH; Baiming Zou, PhD, MS, MA; Julia Adler-Milstein, PhD
Published online: March 24, 2022
© 2022 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
ScienceDirectAccess this article on ScienceDirect
- Factors and reasons associated with low COVID-19 vaccine uptake among highly hesitant communities in the USAmerican Journal of Infection ControlVol. 50Issue 3
- PreviewAs of May 30, 2021 approximately only 50% of the total US adult population received full vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) after the resulting novel coronavirus disease 2019 (COVID-19) contributed to nearly 600,000 deaths in the US and millions of lives globally.1-3 It is critical to achieve high rates of full COVID-19 vaccination among US adults to build herd immunity, and thereby reduce case and death rates.4,5 In addition, high vaccination rates can have economic benefits including cost savings due to lower COVID-19 Emergency Department (ED) visits 6 and improved work productivity due to reduced illness and recovery periods as well as social benefits such as health equity from free vaccines to the public and improved life expectancy among vaccinated people.